The international PSAD Group (formerly known as the PSAD Study Group) was founded by Emeritus Professor Frank Snoek in 1995. From 1997 to 2022, it was an official study group of the European Association for the Study of Diabetes (EASD). You can read Professor Snoek’s reflections on the inception and progress of the PSAD Group here.
The international PSAD Group has been instrumental in promoting leading international collaborations, which have stretched beyond Europe to the US, Canada, South America and Australia.
In particular, these include:
- the Diabetes Attitudes, Wishes and Needs (DAWN) study, a large global study of the psychosocial needs of people with diabetes – a global initiative of Novo Nordisk in collaboration with the PSAD Group and the International Diabetes Federation (IDF)
- the DAWN2 study
- and the European Depression in Diabetes (EDID) research consortium, which explores and promotes consensus on the management of depression in people with diabetes
- numerous other collaborations, which have been developed by researchers who have met via the PSAD Group
In 2020, the 25th anniversary of the PSAD Group meeting was commemorated with a special issue of Diabetic Medicine, including 14 papers providing a summary of advancements in the field of behavioural and psychosocial diabetes research over a quarter of a century.